130 related articles for article (PubMed ID: 6872344)
1. Activation of the alternative pathway of complement by monosodium urate crystals.
Fields TR; Abramson SB; Weissmann G; Kaplan AP; Ghebrehiwet B
Clin Immunol Immunopathol; 1983 Feb; 26(2):249-57. PubMed ID: 6872344
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
Doherty M; Whicher JT; Dieppe PA
Ann Rheum Dis; 1983 Jun; 42(3):285-91. PubMed ID: 6407405
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals.
Giclas PC; Ginsberg MH; Cooper NR
J Clin Invest; 1979 Apr; 63(4):759-64. PubMed ID: 438335
[TBL] [Abstract][Full Text] [Related]
4. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis.
Tramontini N; Huber C; Liu-Bryan R; Terkeltaub RA; Kilgore KS
Arthritis Rheum; 2004 Aug; 50(8):2633-9. PubMed ID: 15334478
[TBL] [Abstract][Full Text] [Related]
5. Effect of IgG and C-reactive protein on complement depletion by monosodium urate crystals.
Russell IJ; Papaioannou C; McDuffie FC; MacIntyre S; Kushner I
J Rheumatol; 1983 Jun; 10(3):425-33. PubMed ID: 6887165
[TBL] [Abstract][Full Text] [Related]
6. Superoxide anion generation by human neutrophils exposed to monosodium urate.
Abramson S; Hoffstein ST; Weissmann G
Arthritis Rheum; 1982 Feb; 25(2):174-80. PubMed ID: 6279115
[TBL] [Abstract][Full Text] [Related]
7. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals.
Scott P; Ma H; Viriyakosol S; Terkeltaub R; Liu-Bryan R
J Immunol; 2006 Nov; 177(9):6370-8. PubMed ID: 17056568
[TBL] [Abstract][Full Text] [Related]
8. Natural antibodies and CRP drive anaphylatoxin production by urate crystals.
Wessig AK; Hoffmeister L; Klingberg A; Alberts A; Pich A; Brand K; Witte T; Neumann K
Sci Rep; 2022 Mar; 12(1):4483. PubMed ID: 35296708
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of complement by gold sodium thiomalate.
Hasselbacher P
J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
[TBL] [Abstract][Full Text] [Related]
10. C3 activation by monosodium urate monohydrate and other crystalline material.
Hasselbacher P
Arthritis Rheum; 1979 Jun; 22(6):571-8. PubMed ID: 110337
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical and ultrastructural characterization of serum proteins associated with monosodium urate crystals (MSU) in synovial fluid cells from patients with gout.
Cherian PV; Schumacher HR
Ultrastruct Pathol; 1986; 10(3):209-19. PubMed ID: 3715998
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface.
Russell IJ; Mansen C; Kolb LM; Kolb WP
Clin Immunol Immunopathol; 1982 Aug; 24(2):239-50. PubMed ID: 6749358
[No Abstract] [Full Text] [Related]
13. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B.
Jaramillo M; Naccache PH; Olivier M
J Immunol; 2004 May; 172(9):5734-42. PubMed ID: 15100320
[TBL] [Abstract][Full Text] [Related]
14. Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout.
Bomalaski JS; Lluberas G; Schumacher HR
Arthritis Rheum; 1986 Dec; 29(12):1480-4. PubMed ID: 3801071
[TBL] [Abstract][Full Text] [Related]
15. Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells.
Xiao J; Fu C; Zhang X; Zhu D; Chen W; Lu Y; Ye Z
Mol Immunol; 2015 Aug; 66(2):310-8. PubMed ID: 25909495
[TBL] [Abstract][Full Text] [Related]
16. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.
Pascual E; Sivera F
Ann Rheum Dis; 2007 Aug; 66(8):1056-8. PubMed ID: 17223663
[TBL] [Abstract][Full Text] [Related]
17. Monosodium urate crystals in asymptomatic knee joints.
Gordon TP; Bertouch JV; Walsh BR; Brooks PM
J Rheumatol; 1982; 9(6):967-9. PubMed ID: 7161792
[TBL] [Abstract][Full Text] [Related]
18. Interactions between tenocytes and monosodium urate monohydrate crystals: implications for tendon involvement in gout.
Chhana A; Callon KE; Dray M; Pool B; Naot D; Gamble GD; Coleman B; McCarthy G; McQueen FM; Cornish J; Dalbeth N
Ann Rheum Dis; 2014 Sep; 73(9):1737-41. PubMed ID: 24709860
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the crystallization of monosodium urate: a systematic literature review.
Chhana A; Lee G; Dalbeth N
BMC Musculoskelet Disord; 2015 Oct; 16():296. PubMed ID: 26467213
[TBL] [Abstract][Full Text] [Related]
20. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model.
Ortiz-Bravo E; Sieck MS; Schumacher HR
Arthritis Rheum; 1993 Sep; 36(9):1274-85. PubMed ID: 8216421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
